Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research report report published on Friday. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Price Performance

Shares of AMPE stock remained flat at $0.00 during midday trading on Friday. 4,702 shares of the company’s stock were exchanged, compared to its average volume of 66,601. The company has a market cap of $2,508.00, a P/E ratio of 0.00 and a beta of 3.73. Ampio Pharmaceuticals has a one year low of $0.00 and a one year high of $7.47.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.